PMC:7283670 / 40264-41299 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T126","span":{"begin":152,"end":157},"obj":"Body_part"},{"id":"T127","span":{"begin":297,"end":302},"obj":"Body_part"},{"id":"T128","span":{"begin":396,"end":405},"obj":"Body_part"},{"id":"T129","span":{"begin":500,"end":504},"obj":"Body_part"},{"id":"T130","span":{"begin":631,"end":635},"obj":"Body_part"}],"attributes":[{"id":"A126","pred":"fma_id","subj":"T126","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A127","pred":"fma_id","subj":"T127","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A128","pred":"fma_id","subj":"T128","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A129","pred":"fma_id","subj":"T129","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A130","pred":"fma_id","subj":"T130","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T78","span":{"begin":152,"end":157},"obj":"Body_part"},{"id":"T79","span":{"begin":297,"end":302},"obj":"Body_part"},{"id":"T80","span":{"begin":500,"end":504},"obj":"Body_part"},{"id":"T81","span":{"begin":631,"end":635},"obj":"Body_part"}],"attributes":[{"id":"A78","pred":"uberon_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A79","pred":"uberon_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A80","pred":"uberon_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A81","pred":"uberon_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T224","span":{"begin":343,"end":353},"obj":"Disease"},{"id":"T225","span":{"begin":367,"end":378},"obj":"Disease"},{"id":"T226","span":{"begin":453,"end":455},"obj":"Disease"},{"id":"T227","span":{"begin":863,"end":872},"obj":"Disease"},{"id":"T228","span":{"begin":892,"end":910},"obj":"Disease"},{"id":"T229","span":{"begin":1027,"end":1035},"obj":"Disease"}],"attributes":[{"id":"A224","pred":"mondo_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/MONDO_0003785"},{"id":"A225","pred":"mondo_id","subj":"T225","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A226","pred":"mondo_id","subj":"T226","obj":"http://purl.obolibrary.org/obo/MONDO_0017941"},{"id":"A227","pred":"mondo_id","subj":"T227","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A228","pred":"mondo_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/MONDO_0004335"},{"id":"A229","pred":"mondo_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T371","span":{"begin":119,"end":124},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T372","span":{"begin":119,"end":124},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T373","span":{"begin":137,"end":141},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T374","span":{"begin":152,"end":157},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T375","span":{"begin":152,"end":157},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T376","span":{"begin":297,"end":302},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T377","span":{"begin":297,"end":302},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T378","span":{"begin":500,"end":504},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T379","span":{"begin":500,"end":504},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T380","span":{"begin":631,"end":635},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T381","span":{"begin":631,"end":635},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T382","span":{"begin":641,"end":642},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T383","span":{"begin":789,"end":792},"obj":"http://purl.obolibrary.org/obo/CLO_0053001"},{"id":"T384","span":{"begin":842,"end":845},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T385","span":{"begin":912,"end":914},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T386","span":{"begin":983,"end":984},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T96","span":{"begin":314,"end":320},"obj":"Chemical"},{"id":"T97","span":{"begin":449,"end":452},"obj":"Chemical"}],"attributes":[{"id":"A96","pred":"chebi_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A97","pred":"chebi_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}

{"project":"LitCovid-sentences","denotations":[{"id":"T382","span":{"begin":0,"end":185},"obj":"Sentence"},{"id":"T383","span":{"begin":186,"end":223},"obj":"Sentence"},{"id":"T384","span":{"begin":224,"end":303},"obj":"Sentence"},{"id":"T385","span":{"begin":304,"end":332},"obj":"Sentence"},{"id":"T386","span":{"begin":333,"end":354},"obj":"Sentence"},{"id":"T387","span":{"begin":355,"end":379},"obj":"Sentence"},{"id":"T388","span":{"begin":380,"end":406},"obj":"Sentence"},{"id":"T389","span":{"begin":407,"end":432},"obj":"Sentence"},{"id":"T390","span":{"begin":433,"end":481},"obj":"Sentence"},{"id":"T391","span":{"begin":482,"end":514},"obj":"Sentence"},{"id":"T392","span":{"begin":515,"end":526},"obj":"Sentence"},{"id":"T393","span":{"begin":527,"end":555},"obj":"Sentence"},{"id":"T394","span":{"begin":556,"end":584},"obj":"Sentence"},{"id":"T395","span":{"begin":585,"end":788},"obj":"Sentence"},{"id":"T396","span":{"begin":789,"end":804},"obj":"Sentence"},{"id":"T397","span":{"begin":805,"end":811},"obj":"Sentence"},{"id":"T398","span":{"begin":812,"end":826},"obj":"Sentence"},{"id":"T399","span":{"begin":827,"end":841},"obj":"Sentence"},{"id":"T400","span":{"begin":842,"end":911},"obj":"Sentence"},{"id":"T401","span":{"begin":912,"end":936},"obj":"Sentence"},{"id":"T402","span":{"begin":937,"end":1035},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T118","span":{"begin":343,"end":353},"obj":"Phenotype"},{"id":"T119","span":{"begin":367,"end":378},"obj":"Phenotype"},{"id":"T120","span":{"begin":419,"end":431},"obj":"Phenotype"},{"id":"T121","span":{"begin":782,"end":787},"obj":"Phenotype"},{"id":"T122","span":{"begin":805,"end":810},"obj":"Phenotype"}],"attributes":[{"id":"A118","pred":"hp_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/HP_0001882"},{"id":"A119","pred":"hp_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A120","pred":"hp_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/HP_0011227"},{"id":"A121","pred":"hp_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A122","pred":"hp_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/HP_0012735"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1089","span":{"begin":449,"end":452},"obj":"Gene"},{"id":"1090","span":{"begin":453,"end":455},"obj":"Gene"},{"id":"1109","span":{"begin":428,"end":431},"obj":"Gene"},{"id":"1144","span":{"begin":176,"end":184},"obj":"Species"},{"id":"1145","span":{"begin":237,"end":243},"obj":"Species"},{"id":"1146","span":{"begin":739,"end":747},"obj":"Species"},{"id":"1294","span":{"begin":343,"end":353},"obj":"Disease"},{"id":"1295","span":{"begin":367,"end":378},"obj":"Disease"},{"id":"1296","span":{"begin":782,"end":787},"obj":"Disease"},{"id":"1297","span":{"begin":805,"end":810},"obj":"Disease"},{"id":"1298","span":{"begin":863,"end":872},"obj":"Disease"},{"id":"1299","span":{"begin":873,"end":888},"obj":"Disease"},{"id":"1300","span":{"begin":1027,"end":1035},"obj":"Disease"}],"attributes":[{"id":"A1089","pred":"tao:has_database_id","subj":"1089","obj":"Gene:26503"},{"id":"A1090","pred":"tao:has_database_id","subj":"1090","obj":"Gene:51727"},{"id":"A1109","pred":"tao:has_database_id","subj":"1109","obj":"Gene:1401"},{"id":"A1144","pred":"tao:has_database_id","subj":"1144","obj":"Tax:9606"},{"id":"A1145","pred":"tao:has_database_id","subj":"1145","obj":"Tax:9606"},{"id":"A1146","pred":"tao:has_database_id","subj":"1146","obj":"Tax:9606"},{"id":"A1294","pred":"tao:has_database_id","subj":"1294","obj":"MESH:D007970"},{"id":"A1295","pred":"tao:has_database_id","subj":"1295","obj":"MESH:D008231"},{"id":"A1296","pred":"tao:has_database_id","subj":"1296","obj":"MESH:D005334"},{"id":"A1297","pred":"tao:has_database_id","subj":"1297","obj":"MESH:D003371"},{"id":"A1298","pred":"tao:has_database_id","subj":"1298","obj":"MESH:D007239"},{"id":"A1299","pred":"tao:has_database_id","subj":"1299","obj":"MESH:D002561"},{"id":"A1300","pred":"tao:has_database_id","subj":"1300","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Fan et al. (2020), China Retrospective cohort study/three tertiary hospitals of Wenzhou 149/45.11 ± 13.35/81 (54.4%) males Laboratory test, PCR, CT Blood RT‐PCR confirmed patients: Hubei travel/residence history: N=85,\ncontact with people of Hubei: N=49, no traceable exposure history: N=15 Blood:\ndecreased oxygen saturation: 14(9.4%), leukopenia: 33 (24.2%), lymphopenia: 53 (35.6%), low platelets: 20 (13.4%), elevated CRP: 82 (55.0%), ALT/AST/CK and D‐dimer: less common.\nCT: most involved lung segments: 6 and, GGO: 287 segments, mixed opacity: 637 segments, consolidation: 170 segments, lesions: more in the peripheral lung with a patchy form, normal CT on admission: N=17, negative CT: N=12, no significant difference between patients with or without exposure history Fever:\n114/149, 76.5%,\nCough: 87/149, 58.4%,\nExpectoration:\n4 8/149, 32.2%, mild infection/cerebrovascular or digestive diseases:\n52 (34.9%) Negative CT: 10 days, 6.8 (5.0) days 0 (0.0%) Diagnosis: a normal CT cannot exclude the diagnosis of COVID‐19"}